Checkpoint Therapeutics buy D. Boral Capital
Start price
31.03.25
/
50%
€0.50
Target price
31.03.26
€4.43
Performance (%)
-
End price
01.04.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Checkpoint Therapeutics | - | - | - |
| iShares Core DAX® | -1,74 % | 5,98 % | 8,98 % |
| iShares Nasdaq 100 | 2,81 % | 11,83 % | 38,41 % |
| iShares Nikkei 225® | -0,11 % | 11,69 % | 46,68 % |
| iShares S&P 500 | 0,97 % | 7,62 % | 28,14 % |
Comments by D__Boral_Capital for this prediction
In the thread Checkpoint Therapeutics diskutieren
Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $4.80 price target on the stock.
Ratings data for CKPT provided by MarketBeat
In the thread Trading Checkpoint Therapeutics
Die von D__Boral_Capital gewählte maximale Laufzeit wurde überschritten